https://finance.yahoo.com/news/inovios-ino-5401-combination-pd-110000918.html
The only inconsistency I see is Kazia claims Overall survival for TMZ is 12 months, while this article states 15-22 months. Can this be why the market has not been impressed with GDC data? Or is it the number of trial participants?
- Forums
- ASX - By Stock
- KZA
- INO- GBM data
INO- GBM data
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)